Search research articles
Contact Us
Filters
Showing results (21-30 of 138) with videos related to
Page
of 14
Sort By:
Transfusion Medicine (Oxford, England)
|
June 8, 2004
Man, mouse and Duffy genotype-phenotype-specific pharmacokinetics of monocyte chemotactic protein-1
B Jilma, N Akimitsu, N Fukuma, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 14, 2010
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
J M Siller-Matula, B Jilma, K Schrör, et al.
Transfusion
|
June 20, 1998
Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis
P Stohlawetz, G Stiegler, B Jilma, et al.
Thrombosis and Haemostasis
|
March 30, 2000
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100
M Homoncik, B Jilma, N Hergovich, et al.
Journal of Human Hypertension
|
December 21, 2012
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis
U Derhaschnig, C Testori, E Riedmueller, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 16, 2006
Endotoxemia enhances circulating endothelial cells in humans
C J Boos, F B Mayr, G Y H Lip, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 17, 1997
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus
A Kautzky-Willer, P Fasching, B Jilma, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 20, 2006
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans
A O Spiel, F B Mayr, C Firbas, et al.
Circulation
|
July 1, 1997
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex
S Kapiotis, B Jilma, P Quehenberger, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1994
Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins
S Schuller-Petrovic, M Wolzt, K Böhler, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 138) with videos related to
Sort By:
Page
of 14
Transfusion Medicine (Oxford, England)
|
June 8, 2004
Man, mouse and Duffy genotype-phenotype-specific pharmacokinetics of monocyte chemotactic protein-1
B Jilma, N Akimitsu, N Fukuma, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 14, 2010
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
J M Siller-Matula, B Jilma, K Schrör, et al.
Transfusion
|
June 20, 1998
Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis
P Stohlawetz, G Stiegler, B Jilma, et al.
Thrombosis and Haemostasis
|
March 30, 2000
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100
M Homoncik, B Jilma, N Hergovich, et al.
Journal of Human Hypertension
|
December 21, 2012
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis
U Derhaschnig, C Testori, E Riedmueller, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 16, 2006
Endotoxemia enhances circulating endothelial cells in humans
C J Boos, F B Mayr, G Y H Lip, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 17, 1997
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus
A Kautzky-Willer, P Fasching, B Jilma, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 20, 2006
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans
A O Spiel, F B Mayr, C Firbas, et al.
Circulation
|
July 1, 1997
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex
S Kapiotis, B Jilma, P Quehenberger, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1994
Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins
S Schuller-Petrovic, M Wolzt, K Böhler, et al.
Page
of 14